827156--10/10/2006--ZILA_INC

related topics
{product, liability, claim}
{customer, product, revenue}
{property, intellectual, protect}
{cost, operation, labor}
{personnel, key, retain}
{condition, economic, financial}
{capital, credit, financial}
{provision, law, control}
{stock, price, operating}
{cost, contract, operation}
{product, candidate, development}
{stock, price, share}
The sale of the Nutraceuticals Business Unit reduced our revenue by approximately 76%. We may fail to realize the anticipated cost savings, revenue enhancements, product focus, or other benefits expected from our recent disposition of the Nutraceuticals Business Unit and any subsequent acquisition. We have incurred substantial expenses and committed valuable time related to the recent disposition of our Nutraceuticals Business Unit and our ability to successfully execute our business plan is dependent on our ability to obtain adequate financing. We are dependent on a few key products and our growth is dependent on the development of new products. Our proprietary rights may prove difficult to enforce. We have historically been, and will probably be in the future, dependent on a few key customers. We are dependent on our senior management and other key personnel. We and our products are subject to regulatory oversight that could substantially interfere with our ability to do business. We are at risk with respect to product liability claims. We face significant competition that could adversely affect our results of operation and financial condition. If the use of our technology is determined to infringe on the intellectual property rights of others, our business could be harmed. We require certain raw materials for our manufacturing processes that may only be acquired through limited sources. If we are unable to obtain adequate funds on acceptable terms, we may not be able to develop and market our present and potential products. We have, in the past, received minor deficiencies from regulatory agencies related to our manufacturing facilities. Trends, Risks and Uncertainties Related to Our Capital Stock Financing arrangements or other corporate events could dilute existing ownership. In the past, we have experienced volatility in the market price of our common stock and we may experience such volatility in the future. Our Board of Directors may take actions which could dilute current equity ownership or prevent or delay a change in our control.

Full 10-K form ▸

related documents
827156--10/15/2007--ZILA_INC
801898--12/21/2006--JOY_GLOBAL_INC
768408--6/24/2010--CYANOTECH_CORP
31791--2/28/2008--PERKINELMER_INC
768408--6/26/2008--CYANOTECH_CORP
1033905--3/16/2006--LUMINEX_CORP
1000180--2/28/2007--SANDISK_CORP
1110803--2/26/2009--ILLUMINA_INC
827156--10/6/2008--ZILA_INC
1102934--11/27/2007--CABOT_MICROELECTRONICS_CORP
751978--3/15/2007--VICOR_CORP
768408--6/25/2009--CYANOTECH_CORP
856982--3/4/2009--MERIT_MEDICAL_SYSTEMS_INC
27096--9/12/2007--DATASCOPE_CORP
880432--9/28/2009--MISONIX_INC
768408--8/16/2007--CYANOTECH_CORP
880432--9/26/2008--MISONIX_INC
1041379--3/12/2008--AFC_ENTERPRISES_INC
736822--8/1/2006--IMMUCOR_INC
1078723--3/31/2010--INTERNATIONAL_FUEL_TECHNOLOGY_INC
801898--12/21/2007--JOY_GLOBAL_INC
751365--4/16/2010--VIRCO_MFG_CORPORATION
6281--11/25/2008--ANALOG_DEVICES_INC
31791--2/26/2009--PERKINELMER_INC
1263074--3/14/2008--PORTEC_RAIL_PRODUCTS_INC
320121--5/23/2006--TELOS_CORP
95366--1/15/2008--SUNAIR_SERVICES_CORP
25354--4/17/2007--CPI_CORP
736822--7/27/2007--IMMUCOR_INC
912093--8/31/2010--JDS_UNIPHASE_CORP_/CA/